Highlights in gastro-intestinal cancer

Source
Belgian journal of medical oncology - ISSN 1784-7141-12 (2018) p. 182-188
Author(s)

Phase Ib study of the immunocytokine simlukafusp alfa (FAP-IL2v) in combination with cetuximab in patients with head and neck squamous cell carcinoma

Source
Clinical cancer research - ISSN 1078-0432-30:24 (2024) p. 5540-5547
Author(s)
    Aaron R. Hansen, Carlos A. Gomez-Roca, Debbie G.J. Robbrecht, Loic Verlingue, Antoine Italiano, Julie E. Bauman, Neeltje Steeghs, Hans Prenen, Jerome Fayette, James Spicer, Jiaxin Niu, Christin Habigt, Meike Schneider, Stefan Evers, Nassim Sleiman, David Dejardin, Caroline Ardeshir, Daniela Schmid, Christophe Boetsch, Jehad Charo, Anton Kraxner, Volker Teichgraeber, Nino Keshelava, Marcelo R. Bonomi

First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors : results from phase I dose exploration

Source
Annals of oncology - ISSN 0923-7534-35:12 (2024) p. 1138-1147
Author(s)
    J. Rodon, Hans Prenen, A. Sacher, M. Villalona-Calero, N. Penel, A. El Helali, S. Rottey, N. Yamamoto, F. Ghiringhelli, M.E. Goebeler, T. Doi, S. Postel-Vinay, C.-C. Lin, C. Liu, C.-H. Chuang, K. Keyvanjah, T. Eggert, B.H. O'Neil